Rizzani A - Search Results

1

Cell cycle progression or translation control is not essential for vesicular stomatitis virus oncolysis of hepatocellular carcinoma.

Marozin S, De Toni EN, Rizzani A, Altomonte J, Junger A, Schneider G, Thasler WE, Kato N, Schmid RM, Ebert O. Marozin S, et al. Among authors: rizzani a. PLoS One. 2010 Jun 7;5(6):e10988. doi: 10.1371/journal.pone.0010988. PLoS One. 2010. PMID: 20539760 Free PMC article.

2

Posttranslational modification of vesicular stomatitis virus glycoprotein, but not JNK inhibition, is the antiviral mechanism of SP600125.

Marozin S, Altomonte J, Apfel S, Dinh PX, De Toni EN, Rizzani A, Nüssler A, Kato N, Schmid RM, Pattnaik AK, Ebert O. Marozin S, et al. Among authors: rizzani a. J Virol. 2012 May;86(9):4844-55. doi: 10.1128/JVI.06649-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345438 Free PMC article.

3

Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.

Altomonte J, Marozin S, De Toni EN, Rizzani A, Esposito I, Steiger K, Feuchtinger A, Hellerbrand C, Schmid RM, Ebert O. Altomonte J, et al. Among authors: rizzani a. Mol Ther. 2013 Nov;21(11):2032-42. doi: 10.1038/mt.2013.181. Epub 2013 Aug 13. Mol Ther. 2013. PMID: 23939023 Free PMC article.

4

STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.

Marozin S, Altomonte J, Muñoz-Álvarez KA, Rizzani A, De Toni EN, Thasler WE, Schmid RM, Ebert O. Marozin S, et al. Among authors: rizzani a. Cancer Gene Ther. 2015 Jun;22(6):317-25. doi: 10.1038/cgt.2015.23. Epub 2015 May 1. Cancer Gene Ther. 2015. PMID: 25930184

5

Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

Palagyi A, Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schäfer C, Göke B, Schindler D, Gallmeier E. Palagyi A, et al. Among authors: rizzani a. Mol Cancer. 2010 May 28;9:127. doi: 10.1186/1476-4598-9-127. Mol Cancer. 2010. PMID: 20509860 Free PMC article.

6

Expression, cellular distribution, and prognostic relevance of TRAIL receptors in hepatocellular carcinoma.

Kriegl L, Jung A, Engel J, Jackstadt R, Gerbes AL, Gallmeier E, Reiche JA, Hermeking H, Rizzani A, Bruns CJ, Kolligs FT, Kirchner T, Göke B, De Toni EN. Kriegl L, et al. Among authors: rizzani a. Clin Cancer Res. 2010 Nov 15;16(22):5529-38. doi: 10.1158/1078-0432.CCR-09-3403. Epub 2010 Oct 1. Clin Cancer Res. 2010. PMID: 20889918

7

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

Mucha SR, Rizzani A, Gerbes AL, Camaj P, Thasler WE, Bruns CJ, Eichhorst ST, Gallmeier E, Kolligs FT, Göke B, De Toni EN. Mucha SR, et al. Among authors: rizzani a. Gut. 2009 May;58(5):688-98. doi: 10.1136/gut.2008.154625. Epub 2008 Dec 23. Gut. 2009. PMID: 19106147

8

Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1.

Lu S, Török HP, Gallmeier E, Kolligs FT, Rizzani A, Arena S, Göke B, Gerbes AL, De Toni EN. Lu S, et al. Among authors: rizzani a. Oncotarget. 2015 Sep 8;6(26):22167-78. doi: 10.18632/oncotarget.4240. Oncotarget. 2015. PMID: 26259250 Free PMC article.

9

Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.

Kriegl L, Jung A, Horst D, Rizzani A, Jackstadt R, Hermeking H, Gallmeier E, Gerbes AL, Kirchner T, Göke B, De Toni EN. Kriegl L, et al. Among authors: rizzani a. PLoS One. 2012;7(12):e51654. doi: 10.1371/journal.pone.0051654. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284732 Free PMC article.

10

Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis.

De Toni EN, Ziesch A, Rizzani A, Török HP, Hocke S, Lü S, Wang SC, Hucl T, Göke B, Bruns C, Gallmeier E. De Toni EN, et al. Among authors: rizzani a. Oncotarget. 2016 Feb 23;7(8):9477-90. doi: 10.18632/oncotarget.7053. Oncotarget. 2016. PMID: 26843614 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page